BrainsWay Ltd.
BWAY
Rank in Stocks
#12483
Established in Jerusalem, Israel, in 2003, BrainsWay Ltd. specializes globally... Established in Jerusalem, Israel, in 2003, BrainsWay Ltd. specializes globally in creating and distributing advanced, non-invasive neurostimulation therapies designed to address a wide array of mental health and neurological conditions. The company's primary innovation is its Deep Transcranial Magnetic Stimulation (dTMS) platform, which offers treatment for disorders including major and anxious depression, obsessive-compulsive disorder, nicotine addiction, bipolar disorder, post-traumatic stress disorder, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post-stroke rehabilitation, and Parkinson's disease. BrainsWay's solutions are primarily adopted by psychiatric practitioners, hospitals, and medical centers across the United States, Europe, Israel, and other international markets.
Share Price
$11.64
Last synced: 2026-11-09
Market Cap
$465.51M
Change (1 day)
4.39%
Change (1 year)
47.53%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade BrainsWay Ltd. (BWAY)
Category
Healthcare
EPS for BrainsWay Ltd. (BWAY)
EPS as of June 2026 TTM: $0.46
According to BrainsWay Ltd.'s latest financial reports, its current EPS (TTM) is $0.46. At the end of 2025 the company had an EPS of $0.40, an increase over its 2024 EPS of $0.09.
EPS history for BrainsWay Ltd. from 2012 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.46 | 15.00% |
| 2025 | $0.40 | 365.12% |
| 2024 | $0.09 | -166.15% |
| 2023 | $-0.13 | -69.77% |
| 2022 | $-0.43 | 104.76% |
| 2021 | $-0.21 | -12.50% |
| 2020 | $-0.24 | -52.00% |
| 2019 | $-0.50 | 28.21% |
| 2018 | $-0.39 | -18.75% |
| 2017 | $-0.48 | 182.35% |
| 2016 | $-0.17 | -39.29% |
| 2015 | $-0.28 | -39.13% |
| 2014 | $-0.46 | -16.36% |
| 2013 | $-0.55 | 12.24% |
| 2012 | $-0.49 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $8.45 | 1,736.96% |
IE
|
|
| $0.21 | -54.67% |
CN
|
|
| $19.69 | 4,180.17% |
CH
|
|
| $4.34 | 843.04% |
CH
|
|
| $0.13 | -72.61% |
CN
|
Questions about BrainsWay Ltd.'s earnings per share (EPS)
What is BrainsWay Ltd.'s earnings per share (EPS)?
BrainsWay Ltd.'s earnings per share (EPS) over the last twelve months is $0.46, as of Jun 2026.
What was BrainsWay Ltd.'s earnings per share (EPS) in 2025?
In 2025, BrainsWay Ltd.'s earnings per share (EPS) was $0.40, 344.44% more than in 2024 ($0.09).
How has BrainsWay Ltd.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, BrainsWay Ltd.'s earnings per share (EPS) was highest in 2025 ($0.40) and lowest in 2022 ($-0.43).
How does BrainsWay Ltd.'s earnings per share (EPS) compare with similar companies?
BrainsWay Ltd.'s earnings per share (EPS) ($0.46) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Ypsomed Holding AG, with $19.69.